Significados de molecular targeted therapy en inglés

Its therapeutic potential warrants further development for ovarian cancer molecular targeted therapy.

Novel treatment strategies, including molecular targeted therapy, are currently being explored.

Activating EGFR mutations were subsequently discovered in 2004, and heralded the era of molecular targeted therapy in NSCLC.

Purpose of review: This article reviewed the recent developments in molecular targeted therapy in head and neck cancers.

The relatively high prevalence of positive staining for EGFR supports the use of molecular targeted therapy in this disease.

Designing molecular targeted therapy with high specificity based on novel tumor biomarkers is a high priority in lung cancer research.

Several previous studies have found that molecular targeted therapy with tyrosine kinase inhibitors is effective against colorectal cancer with elevated SRC expression.

These results indicate that IL-11Ra is a potential target for the development of molecular targeted therapy and noninvasive tumor imaging in human osteosarcoma.

To determine other tumors in which such a molecular targeted therapy might be indicated, we investigated KIT expression in different human tumor types.

The therapeutic successes achieved are due to advances in neuroimaging, surgical techniques, radiotherapy, and induction of newer chemotherapeutic agents along with molecular targeted therapy.

Molecular targeted therapy represents a novel therapeutic approach.

Molecular targeted therapy represents a promising new strategy for treating cancers because many small-molecule inhibitors targeting protein kinases have recently become available.